{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:56:50Z","timestamp":1787500610252,"version":"build-2736575974"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["2019-AARG-643091"],"award-info":[{"award-number":["2019-AARG-643091"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003770","name":"Bank of Italy","doi-asserted-by":"publisher","award":["1130944\/22"],"award-info":[{"award-number":["1130944\/22"]}],"id":[{"id":"10.13039\/501100003770","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.tem.2025.08.007","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T15:00:41Z","timestamp":1757084441000},"page":"466-479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Biliverdin reductase-A is a key modulator in insulin signaling and metabolism"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9564-2086","authenticated-orcid":false,"given":"Antonella","family":"Tramutola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2013-209X","authenticated-orcid":false,"given":"Fabio","family":"Di Domenico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4668-5239","authenticated-orcid":false,"given":"Marzia","family":"Perluigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7028-4251","authenticated-orcid":false,"given":"Eugenio","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2025.08.007_bb0005","first-page":"38","article-title":"Biliverdin reductase: new features of an old enzyme and its potential therapeutic significance","volume":"60","author":"Florczyk","year":"2008","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.tem.2025.08.007_bb0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jb\/mvaa039","article-title":"Structure, dynamics and function of the evolutionarily changing biliverdin reductase B family","volume":"168","author":"Duff","year":"2020","journal-title":"J. Biochem."},{"key":"10.1016\/j.tem.2025.08.007_bb0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.tips.2008.12.003","article-title":"Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin","volume":"30","author":"Kapitulnik","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tem.2025.08.007_bb0020","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tem.2015.02.001","article-title":"Biliverdin reductase isozymes in metabolism","volume":"26","author":"O\u2019Brien","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tem.2025.08.007_bb0025","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1096\/fj.13-247015","article-title":"Human biliverdin reductase-based peptides activate and inhibit glucose uptake through direct interaction with the kinase domain of insulin receptor","volume":"28","author":"Gibbs","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.tem.2025.08.007_bb0030","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1073\/pnas.0502173102","article-title":"Human biliverdin reductase: a member of the insulin receptor substrate family with serine\/threonine\/tyrosine kinase activity","volume":"102","author":"Lerner-Marmarosh","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2025.08.007_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103221","article-title":"Biliverdin reductase-A integrates insulin signaling with mitochondrial metabolism through phosphorylation of GSK3beta","volume":"73","author":"Lanzillotta","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.tem.2025.08.007_bb0040","doi-asserted-by":"crossref","first-page":"6870","DOI":"10.1073\/pnas.0800750105","article-title":"Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling","volume":"105","author":"Lerner-Marmarosh","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2025.08.007_bb0045","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1096\/fj.07-8544com","article-title":"Regulation of TNF-alpha-activated PKC-zeta signaling by the human biliverdin reductase: identification of activating and inhibitory domains of the reductase","volume":"21","author":"Lerner-Marmarosh","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.tem.2025.08.007_bb0050","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1089\/ars.2007.1805","article-title":"Biliverdin reductase: PKC interaction at the cross-talk of MAPK and PI3K signaling pathways","volume":"9","author":"Maines","year":"2007","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.tem.2025.08.007_bb0055","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3390\/antiox9080671","article-title":"BVR-A deficiency leads to autophagy impairment through the dysregulation of AMPK\/mTOR axis in the brain \u2013 implications for neurodegeneration","volume":"9","author":"Lanzillotta","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.tem.2025.08.007_bb0060","article-title":"Biliverdin reductase A is a major determinant of neuroprotective Nrf2 signaling [preprint]","author":"Vasavda","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.tem.2025.08.007_bb0065","doi-asserted-by":"crossref","DOI":"10.1126\/science.adq6741","article-title":"A metabolite-based resistance mechanism against malaria","volume":"388","author":"Figueiredo","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.tem.2025.08.007_bb0070","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.chembiol.2019.07.006","article-title":"Bilirubin links heme metabolism to neuroprotection by scavenging superoxide","volume":"26","author":"Vasavda","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.tem.2025.08.007_bb0075","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/biom14020155","article-title":"Neuroprotective roles of the biliverdin reductase-A\/bilirubin axis in the brain","volume":"14","author":"Paul","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.tem.2025.08.007_bb0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/antiox12010111","article-title":"Intranasal administration of KYCCSRK peptide rescues brain insulin signaling activation and reduces Alzheimer\u2019s disease-like neuropathology in a mouse model for Down syndrome","volume":"12","author":"Tramutola","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.tem.2025.08.007_bb0085","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1007\/s12035-018-1231-5","article-title":"Biliverdin reductase-A mediates the beneficial effects of intranasal insulin in Alzheimer disease","volume":"56","author":"Barone","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tem.2025.08.007_bb0090","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1096\/fj.201600330RR","article-title":"Interaction of human biliverdin reductase with Akt\/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation","volume":"30","author":"Miralem","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.tem.2025.08.007_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrm.2017.89","article-title":"Biochemical and cellular properties of insulin receptor signalling","volume":"19","author":"Haeusler","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tem.2025.08.007_bb0100","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cmet.2020.01.015","article-title":"AMPK and TOR: the yin and yang of cellular nutrient sensing and growth control","volume":"31","author":"Gonzalez","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2025.08.007_bb0105","doi-asserted-by":"crossref","first-page":"7020","DOI":"10.1038\/s41598-019-43347-8","article-title":"TLR4 counteracts BVRA signaling in human leukocytes via differential regulation of AMPK, mTORC1 and mTORC2","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2025.08.007_bb0110","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1074\/jbc.M108239200","article-title":"Human biliverdin reductase is a leucine zipper-like DNA-binding protein and functions in transcriptional activation of heme oxygenase-1 by oxidative stress","volume":"277","author":"Ahmad","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2025.08.007_bb0115","doi-asserted-by":"crossref","first-page":"8110","DOI":"10.1074\/jbc.M513427200","article-title":"Human biliverdin reductase, a previously unknown activator of protein kinase C betaII","volume":"282","author":"Maines","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2025.08.007_bb0120","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1074\/jbc.M111.279612","article-title":"Formation of ternary complex of human biliverdin reductase-protein kinase Cdelta-ERK2 protein is essential for ERK2-mediated activation of Elk1 protein, nuclear factor-kappaB, and inducible nitric-oxidase synthase (iNOS)","volume":"287","author":"Gibbs","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2025.08.007_bb0125","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI57256","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease-associated Abeta oligomers","volume":"122","author":"Bomfim","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2025.08.007_bb0130","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/BJ20080018","article-title":"Biliverdin reductase is a transporter of haem into the nucleus and is essential for regulation of HO-1 gene expression by haematin","volume":"413","author":"Tudor","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.tem.2025.08.007_bb0135","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1471-4159.2011.07538.x","article-title":"Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease","volume":"120","author":"Barone","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tem.2025.08.007_bb0140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.freeradbiomed.2015.12.012","article-title":"Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: a new paradigm","volume":"91","author":"Barone","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tem.2025.08.007_bb0145","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1016\/j.bbadis.2018.07.005","article-title":"Biliverdin reductase-A impairment links brain insulin resistance with increased Abeta production in an animal model of aging: Implications for Alzheimer disease","volume":"1864","author":"Triani","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.tem.2025.08.007_bb0150","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/biom10030387","article-title":"Biliverdin reductase A (BVRA) knockout in adipocytes induces hypertrophy and reduces mitochondria in white fat of obese mice","volume":"10","author":"Stec","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.tem.2025.08.007_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2019.108072","article-title":"CRISPR Cas9-mediated deletion of biliverdin reductase A (BVRA) in mouse liver cells induces oxidative stress and lipid accumulation","volume":"672","author":"Gordon","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.tem.2025.08.007_bb0160","doi-asserted-by":"crossref","first-page":"25179","DOI":"10.1074\/jbc.M116.731703","article-title":"Biliverdin reductase A attenuates hepatic steatosis by inhibition of glycogen synthase kinase (GSK) 3beta phosphorylation of serine 73 of peroxisome proliferator-activated receptor (PPAR) alpha","volume":"291","author":"Hinds","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2025.08.007_bb0165","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41574-025-01114-y","article-title":"Insulin resistance in type 2 diabetes mellitus","volume":"21","author":"Accili","year":"2025","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.tem.2025.08.007_bb0170","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.bbadis.2019.02.021","article-title":"Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity","volume":"1865","author":"Cimini","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.tem.2025.08.007_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119913","article-title":"Biliverdin reductase-A protein levels are reduced in type 2 diabetes and are associated with poor glycometabolic control","volume":"284","author":"Cimini","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.tem.2025.08.007_bb0180","doi-asserted-by":"crossref","first-page":"9091","DOI":"10.3390\/ijms21239091","article-title":"Reduced biliverdin reductase-A expression in visceral adipose tissue is associated with adipocyte dysfunction and NAFLD in human obesity","volume":"21","author":"Ceccarelli","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2025.08.007_bb0185","doi-asserted-by":"crossref","first-page":"7282","DOI":"10.3390\/ijms24087282","article-title":"Dynamic changes of BVRA protein levels occur in response to insulin: a pilot study in humans","volume":"24","author":"Cimini","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2025.08.007_bb0190","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57849","article-title":"Whole-genome sequencing analysis of semi-supercentenarians","volume":"10","author":"Garagnani","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.tem.2025.08.007_bb0195","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jdi.70020","article-title":"Predictive value of biliverdin reductase-A and homeostasis model assessment of insulin resistance on mild cognitive impairment in patients with type 2 diabetes","volume":"16","author":"Shen","year":"2025","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.tem.2025.08.007_bb0200","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tem.2025.04.010","article-title":"Expanding the understanding of insulin resistance in brain and periphery","volume":"37","author":"Chen","year":"2026","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tem.2025.08.007_bb0205","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/alz.12130","article-title":"Extracellular vesicle biomarkers of Alzheimer\u2019s disease associated with sub-clinical cognitive decline in late middle age","volume":"16","author":"Eren","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tem.2025.08.007_bb0210","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/hbm.23494","article-title":"Exosomal biomarkers of brain insulin resistance associated with regional atrophy in Alzheimer\u2019s disease","volume":"38","author":"Mullins","year":"2017","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.tem.2025.08.007_bb0215","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jamaneurol.2019.2462","article-title":"Association of extracellular vesicle biomarkers with Alzheimer disease in the Baltimore Longitudinal Study of Aging","volume":"76","author":"Kapogiannis","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.tem.2025.08.007_bb0220","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3233\/JAD-230555","article-title":"Malignant brain aging: the formidable link between dysregulated signaling through mechanistic target of rapamycin pathways and Alzheimer\u2019s disease (type 3 diabetes)","volume":"95","author":"de la Monte","year":"2023","journal-title":"J Alzheimer's Dis"},{"key":"10.1016\/j.tem.2025.08.007_bb0225","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tem.2025.08.007_bb0230","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1152\/physrev.00030.2022","article-title":"Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease","volume":"104","author":"Perluigi","year":"2024","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tem.2025.08.007_bb0235","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","article-title":"Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums","volume":"14","author":"Arnold","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tem.2025.08.007_bb0240","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1042\/BST20220789","article-title":"Loss of brain energy metabolism control as a driver for memory impairment upon insulin resistance","volume":"51","author":"Duarte","year":"2023","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.tem.2025.08.007_bb0245","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41583-022-00558-9","article-title":"Impaired insulin signalling and allostatic load in Alzheimer disease","volume":"23","author":"De Felice","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tem.2025.08.007_bb0250","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.freeradbiomed.2021.01.042","article-title":"Insulin resistance, oxidative stress and mitochondrial defects in Ts65dn mice brain: a harmful synergistic path in down syndrome","volume":"165","author":"Lanzillotta","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tem.2025.08.007_bb0255","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bbadis.2011.01.005","article-title":"Biliverdin reductase-A protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment","volume":"1812","author":"Barone","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tem.2025.08.007_bb0260","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.nbd.2019.02.003","article-title":"Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer\u2019s disease","volume":"125","author":"Sharma","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tem.2025.08.007_bb0265","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/JAD-2012-121045","article-title":"HO-1\/BVR-A system analysis in plasma from probable Alzheimer\u2019s disease and mild cognitive impairment subjects: a potential biochemical marker for the prediction of the disease","volume":"32","author":"Di Domenico","year":"2012","journal-title":"J Alzheimer's Dis"},{"key":"10.1016\/j.tem.2025.08.007_bb0270","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3233\/JAD-2011-110092","article-title":"Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer\u2019s disease and amnestic mild cognitive impairment","volume":"25","author":"Barone","year":"2011","journal-title":"J Alzheimer's Dis"},{"key":"10.1016\/j.tem.2025.08.007_bb0275","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abh3066","article-title":"Biliverdin reductase bridges focal adhesion kinase to Src to modulate synaptic signaling","volume":"15","author":"Vasavda","year":"2022","journal-title":"Sci. Signal."},{"key":"10.1016\/j.tem.2025.08.007_bb0280","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.tcb.2020.03.001","article-title":"Folding the mitochondrial UPR into the integrated stress response","volume":"30","author":"Anderson","year":"2020","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.tem.2025.08.007_bb0285","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.aax3768","article-title":"Mitocellular communication: shaping health and disease","volume":"366","author":"Mottis","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.tem.2025.08.007_bb0290","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5628946","article-title":"Biliverdin reductase A protects lens epithelial cells against oxidative damage and cellular senescence in age-related cataract","volume":"2022","author":"Huang","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.tem.2025.08.007_bb0295","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.freeradbiomed.2017.11.020","article-title":"Absence of the biliverdin reductase-A gene is associated with increased endogenous oxidative stress","volume":"115","author":"Chen","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tem.2025.08.007_bb0300","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1159\/000485580","article-title":"The key roles of GSK-3beta in regulating mitochondrial activity","volume":"44","author":"Yang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.tem.2025.08.007_bb0305","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4712053","article-title":"Nanoparticle delivered human biliverdin reductase-based peptide increases glucose uptake by activating IRK\/Akt\/GSK3 axis: the peptide is effective in the cell and wild-type and diabetic Ob\/Ob mice","volume":"2016","author":"Gibbs","year":"2016","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.tem.2025.08.007_bb0310","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.3390\/ijms21082672","article-title":"Tat-biliverdin reductase A exerts a protective role in oxidative stress-induced hippocampal neuronal cell damage by regulating the apoptosis and MAPK signaling","volume":"21","author":"Kim","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2025.08.007_bb0315","doi-asserted-by":"crossref","first-page":"24698","DOI":"10.1074\/jbc.M111.326504","article-title":"The human biliverdin reductase-based peptide fragments and biliverdin regulate protein kinase Cdelta activity: the peptides are inhibitors or substrate for the protein kinase C","volume":"287","author":"Miralem","year":"2012","journal-title":"J. Biol. Chem."}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276025001766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276025001766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:40:07Z","timestamp":1778794807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276025001766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1043276025001766"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2025.08.007","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biliverdin reductase-A is a key modulator in insulin signaling and metabolism","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2025.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}